Nextleaf Solutions Ltd.’s (OTCQB:OILFF) (CSE:OILS) (FSE:L0MA) technology to produce THC-free broad spectrum CBD distillate ("THC-Free CBD") from industrial hemp feedstock has been validated.

Nextleaf is commercializing its patented technology by utilizing its new distillate-based ingredient to power the next generation of innovative CBD products distributed under the company's prohibition-era brand, Glacial Gold, and supplying bulk THC-Free CBD ingredients to leading global CPG manufacturers in Canada and where cannabinoids are legal.

The company's cannabinoid-based products are distributed in British Columbia, Saskatchewan, Ontario, Nova Scotia and nationally to medical patients through distribution partners.

The company recently produced THC-Free CBD in anticipation of commercialization and has validated its hemp extraction and manufacturing process through third-party analytical testing. Nextleaf expects to release more details in the coming weeks on the launch of its first THC-Free CBD product, and the sale of bulk cannabinoids to B2B customers that require CBD compliant for distribution in Canada and intentionally.

Under the Cannabis Act, a pure CBD product is defined as CBD containing less than 0.3% THC. The company's intellectual property stack covers the extraction and distillation of industrial hemp and uses the new technology to further refine the CBD distillate below the defined threshold. The result is an excise tax-free, broad-spectrum, THC-Free CBD ingredient that may have mass market therapeutic and wellness appeal for consumers looking for all the benefits of CBD with the minor cannabinoids found within the plant, without the THC effects.

Photo: Courtesy of Nextleaf Solutions Ltd.

Related News

Nextleaf Launches Glacial Gold CBD 3:1 Vape

Nextleaf To Launch THC-O As An Excise Tax-Free Alternative To Delta-9-THC

Nextleaf Q2 2022 Revenue Grows 774% YoY, Reports Management Changes